Sapient Extends Multi-Omics Services with High Throughput Discovery Proteomics

These services enable measure of thousands of proteins in blood and tissue across diverse biological pathways.

Dynamic biomarkers to optimize bioprocessing: scale up cell line productivity

How discovery mass spectrometry can be used to identify biomarkers to analyze, monitor & optimize bioprocessing workflows.

OMG OMx Podcast: A Conversation on All Things Omics with Dr. Tanya Nguyen

Dr. Nguyen joins Bruker’s Kate Stumpo for a wide-ranging conversation on her experiences in the field of omics.

Bioanalysis Zone Feature: “Discovery technologies for the multi-omics era of precision medicine”

Sapient’s Dr. Mo Jain discusses the role next-generation mass spectrometry will play in the evolution of precision drug development.

Sapient Multi-Omics Biomarker Discovery Services

See how we deliver bespoke services for metabolomics, lipidomics, and proteomics data generation and analysis.

Discovery Proteomics Fact Sheet

See how our methods enable deep coverage of the blood & tissue proteome, and are scalable to your throughput needs.

Advancing Population Health insights with the addition of dynamic biomarkers

Population health studies finally have an efficient, scalable approach to ‘go beyond the genome’ in biomarker discovery.

Join us at Biomarkers UK 2024

Sapient will be attending and presenting at Europe’s flagship event for biomarker research. See where you can meet us.

Talk to Your Pharmacist Podcast: Success Occurs in the Margins with Nontargeted Discovery

Dr. Jain shares how nontargeted biomarker discovery provides a nontraditional path to advance drug development.

Discovery through data transparency: at the heart of scientific collaboration

Why data transparency is imperative to ensure the accuracy and reproducibility of findings that inform drug development.